CANbridge Life Sciences is a biopharmaceutical company accelerating development and commercialization of specialty healthcare products for serious and critical medical conditions in China and North Asia. The Company has the capability to select, acquire, develop and deliver future therapeutics and diagnostics with high potential to meet seriously unmet medical needs.CANbridge also licenses or obtains exclusive rights to commercialize drug and device products that are approved in their home markets for commercialization.